Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:LJPC

La Jolla Pharmaceutical (LJPC) Stock Price, News & Analysis

La Jolla Pharmaceutical logo

About La Jolla Pharmaceutical Stock (NASDAQ:LJPC)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$3.12
$6.22
52-Week Range
N/A
Volume
66,708 shs
Average Volume
158,476 shs
Market Capitalization
$155.11 million
P/E Ratio
51.84
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive LJPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for La Jolla Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

LJPC Stock News Headlines

Buffett’s $325 Billion Cash Problem — Solved by Gold?
A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most investors are still asleep… but not for long. Garrett Goggin’s latest research reveals how you can “front-run” the greatest investor alive by positioning in four small miners sitting on up to 100X potential upside. When this hits the news — it’ll be too late.
See More Headlines

LJPC Stock Analysis - Frequently Asked Questions

La Jolla Pharmaceutical (NASDAQ:LJPC) issued its quarterly earnings data on Monday, May, 16th. The biopharmaceutical company reported ($0.15) EPS for the quarter, missing analysts' consensus estimates of $0.01 by $0.16. The biopharmaceutical company had revenue of $10.43 million for the quarter, compared to the consensus estimate of $13.10 million. La Jolla Pharmaceutical had a negative trailing twelve-month return on equity of 5.46% and a net margin of 8.54%.

Based on aggregate information from My MarketBeat watchlists, some other companies that La Jolla Pharmaceutical investors own include BioCryst Pharmaceuticals (BCRX), El Pollo Loco (LOCO), Intercept Pharmaceuticals (ICPT), Bristol Myers Squibb (BMY), Exelixis (EXEL), Sarepta Therapeutics (SRPT) and Inovio Pharmaceuticals (INO).

Company Calendar

Last Earnings
5/16/2022
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:LJPC
CIK
920465
Employees
61
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$0.12
Trailing P/E Ratio
51.84
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$19.66 million
Net Margins
8.54%
Pretax Margin
8.64%
Return on Equity
-5.46%
Return on Assets
4.00%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.02
Quick Ratio
3.52

Sales & Book Value

Annual Sales
$75.72 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
7.95
Book Value
($2.94) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
24,937,000
Free Float
15,885,000
Market Cap
$155.11 million
Optionable
Optionable
Beta
2.39

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:LJPC) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners